Analysed Hyphens Pharma International Ltd (1J5:SGX) News Sources
Hyphens Pharma profit dives 44% in 2025 despite record 40.7% gross margins
Singapore Business Review
Which Is a Better Investment, Celldex Therapeutics, Inc. or Halozyme Therapeutics, Inc. Stock?
American Association of Individual Investors
Making complex and innovative products at scale, the next frontier, say pharma chiefs
The Hindu BusinessLine
Pharma exports grow 9.4% to $30.47 billion in FY25; industry eyes double-digit expansion by 2026-27
The Times of India
Pharma exports up 9.4% in FY25; industry aims for double-digit expansion in 2026-27
The Hindu BusinessLine
Triple agonist UBT251 delivers up to 19.7% mean weight loss after 24 weeks in phase 2 trial in China
Arabian Post on MSN
90% of country’s cough syrup units inspected; 850 CAPA notices issued in quality crackdown: DCGI
The Indian Express
What is the current price of Hyphens Pharma International Ltd (1J5:SGX)?
The current price of Hyphens Pharma International Ltd (1J5:SGX) is $0.335.
Hyphens Pharma International Ltd (1J5:SGX) absolute price change since previous trading day?
The absolute price change of Hyphens Pharma International Ltd (1J5:SGX) since the previous trading day is $-0.01.
Hyphens Pharma International Ltd (1J5:SGX) percentage price change since previous trading day?
The percentage price change of Hyphens Pharma International Ltd (1J5:SGX) since the previous trading day is -1.47%.
What is This Week's average sentiment score for Hyphens Pharma International Ltd (1J5:SGX)?
This Week's average sentiment score for Hyphens Pharma International Ltd (1J5:SGX) is 46 out of 100.
What is This Week's average sentiment for Hyphens Pharma International Ltd (1J5:SGX)?
This Week's sentiment for Hyphens Pharma International Ltd (1J5:SGX) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.